News | February 12, 2021
Approval accorded under PLI Scheme for domestic manufacturing of medical devices
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
The commercial production in the SML was started in November 1989.
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
This makes the company among few in India to offer fully integrated, end-to-end ADC drug substance development and manufacturing, encompassing payload synthesis, linker development and manufacturing
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
Subscribe To Our Newsletter & Stay Updated
